136941-85-0 Usage
Molecular structure
The compound consists of a benzisothiazolone ring, a tetrahydro-2H-pyran ring, and a dihydropyridine ring, with various substituents such as ethyl, methyl, and nitrophenyl groups attached to it.
Functional groups
The molecule contains multiple functional groups, including a 1,1-dioxide, a 3-oxo group in the benzisothiazolone ring, and a 2,6-dimethyl group in the dihydropyridine ring.
Potential pharmacological activities
Due to its complex structure and multiple functional groups, the compound may exhibit a wide range of pharmacological activities, making it a potential candidate for drug development or as a precursor for drug synthesis.
Further studies and testing
The precise biological activities and potential pharmacological uses of this compound would need to be evaluated through additional research, including in vitro and in vivo testing, to determine its safety and efficacy for specific medical applications.
Check Digit Verification of cas no
The CAS Registry Mumber 136941-85-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,6,9,4 and 1 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 136941-85:
(8*1)+(7*3)+(6*6)+(5*9)+(4*4)+(3*1)+(2*8)+(1*5)=150
150 % 10 = 0
So 136941-85-0 is a valid CAS Registry Number.
136941-85-0Relevant articles and documents
Synthesis of 3-1,4-Dihydropyridine-3,5-dicarboxylate Derivaties as Calcium Channel Modulators
Sunkel, Carlos E.,Casa-Juana, Miguel Fau de,Santos, Luis,Garcia, Antonio G.,Artalejo, Cristina R.,et al.
, p. 2407 - 2414 (2007/10/02)
1,4-Dihydropyridine (DHP) derivatives with a 1,2-benzisothiazol-3-one 1,1-dioxide group, linked through an alkylene bridge to the C-3 carboxylate of the DHP ring, with both vasoconstricting and vasorelaxant properties were obtained.In blocking Ca2+/
